Exchange: OTC Sector: Healthcare Industry: Biotechnology
0.00% $0.0600
America/New_York / 1 mai 2024 @ 12:20
FUNDAMENTALS | |
---|---|
MarketCap: | 2.43 mill |
EPS: | -0.0900 |
P/E: | -0.670 |
Earnings Date: | Jun 03, 2024 |
SharesOutstanding: | 40.52 mill |
Avg Daily Volume: | 0.0057 mill |
RATING 2024-05-01 |
---|
C |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Sell | |
DE: | Strong Sell | |
P/E: | Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | n/a | |||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.670 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0.00x |
Company: PE -0.670 | industry: PE 136.10 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 0.0410 - 0.0790 ( +/- 31.67%) |
ATR Model: 14 days |